ICD-10-CM Billable Code

E70.329

Oculocutaneous albinism, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Oculocutaneous albinism is a genetic condition characterized by a significant reduction or absence of pigment in the skin, hair, and eyes. This condition affects the production of melanin, the pigment responsible for coloring these tissues. Individuals with this condition often have very light skin and hair, along with eye problems that can affect vision. The specific code E70.329 pertains to cases where the exact type of albinism has not been specified, providing a broad classification for this diverse group of genetic disorders.

Causes & Symptoms

Clinical Causes: Mutations in genes involved in melanin production, most commonly the TYR, OCA2, TYRP1, and SLC45A2 genes. Inherited in an autosomal recessive pattern, meaning a person inherits a defective gene from both parents. Genetic variations or mutations interfere with the normal development and distribution of melanin in the body. While most cases are inherited, rare instances may result from new mutations with no previous family history.

Key Symptoms: Very light or white skin that is more susceptible to sunburn and skin damage. Light-colored or white hair that often appears very fine or sparse. Visual problems such as nystagmus (involuntary eye movement), reduced visual acuity, and increased sensitivity to light (photophobia). Lack of pigmentation in the iris, leading to a very light or pinkish appearance. Potential development of skin and eye complications, including an increased risk for skin cancer and vision impairments.

Diagnostic & Treatment

Diagnosis Path: Diagnosing oculocutaneous albinism typically involves a thorough physical examination and assessment of skin, hair, and eye pigmentation. Eye examinations are critical to evaluate visual acuity, eye movements, and pigment abnormalities. Genetic testing can identify mutations in specific genes associated with the condition. In some cases, family history and prenatal testing are also employed to confirm the diagnosis early in life.

Treatment Protocols: Regular skin protection against UV radiation to prevent sunburn and reduce skin cancer risk, such as using high-SPF sunscreens, protective clothing, and sunglasses. Vision correction methods, including glasses, contact lenses, or surgical interventions if necessary. Use of magnifiers or other assistive devices to help with visual tasks. Regular eye check-ups to monitor and manage visual conditions. Educational and social support to address potential developmental or social challenges stemming from appearance differences. Genetic counseling for affected families to understand inheritance patterns and reproductive options.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E70.329 a billable ICD-10 code?
Yes, E70.329 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E70.329?
Clinical documentation must specify the nature of Oculocutaneous albinism, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference